Pharmacopeia Changes Name to Accelrys | GenomeWeb

NEW YORK, May 21 (GenomeWeb News) - Pharmacopeia has changed its name to Accelrys, the company said yesterday.

 

Stockholders approved the name change on May 11. After spinning off its drug discovery business, Accelrys is now solely focused on delivering scientific software to the life science and materials research industries.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.